Future research should continue to explore new targets, optimize combination therapy regimens, and develop safer and more effective delivery systems to fully realize the potential of FGF19/FGFR4-targeted therapy, thereby providing more effective treatment options and better prognoses for cancer patients. This evidence concerns the gene FGF19 and cancer.